Tradestie Institutional Equity Comparison Engine

IRMD vs DCTH โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

IRMD Overall Edge

IRMD Captures Institutional Edge (2โ€“2 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to iRadimed Corporation (IRMD) driven by superior Valuation, Growth & Margin while DCTH counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, IRMD trades at 35.0x Forward P/E with 32.3% operating margin (+14.2% YoY revenue) versus DCTH at N/M Forward P/E and 5.2% operating margin (+70.7% YoY). In options structure, IRMD sits in CONSOLIDATION (5th %ile IV; Dealer Gamma Walls on Pro) against DCTH sits in BREAKOUT (43rd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner IRMD
IRMD 35.0x vs DCTH N/M Fwd P/E
Growth & Margin Winner IRMD
Op Margin 32.3% vs 5.2% ยท YoY +14.2% vs +70.7%
Momentum & Technical Winner DCTH
1Y -0.1% vs +128.6% ยท 52W Pos 26% vs 80%
Options & Structure Winner DCTH
CONSOLIDATION (5th %ile IV) vs BREAKOUT (43rd %ile IV)
IRMD NASDAQ
iRadimed Corporation
Surgical & Medical Instruments & Apparatus
$84.42
-1.08% 1D
Market Cap $1.1B
1M Return -4.36%
1Y Return -0.09%
Forward P/E 35.0x
Unified AI Score
40.3 / 100 SELL
Tech 29.0 Fund 41.0 Flow 67.0 Mom 50.0
DCTH NASDAQ
Delcath Systems Inc
Surgical & Medical Instruments & Apparatus
$19.68
-4.23% 1D
Market Cap $743.8M
1M Return +39.77%
1Y Return +128.57%
Forward P/E N/M
Unified AI Score
35.9 / 100 SELL
Tech 50.0 Fund 38.0 Flow 60.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: IRMD -0.09% DCTH +128.57% Spread: +128.66 pp (DCTH Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period IRMD Revenue DCTH Revenue IRMD Op. Margin DCTH Op. Margin Margin Edge
FY2018 $30M N/A 19.7% N/A IRMD
FY2019 $40M N/A 22.5% N/A IRMD
FY2020 $30M N/A -2.4% N/A IRMD
FY2021 $40M $0M 23.5% -690.0% IRMD
FY2022 $50M $0M 29.3% -1245.1% IRMD
FY2023 $70M $0M 30.6% -1849.0% IRMD
FY2024 $70M $40M 30.0% -33.4% IRMD
FY2025 $80M $90M 31.2% 0.8% IRMD

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: IRMD (8) vs DCTH (2)
Institutional Metric IRMD DCTH Criterion Row Winner
Market Capitalization Scale $1.1B $743.8M Larger Scale IRMD
Trailing P/E Ratio Valuation 45.3x 133.6x Lower Multiple IRMD
Forward P/E Ratio Valuation 35.0x N/M Lower Multiple IRMD
Revenue Growth (YoY) Growth +14.2% +70.7% Higher Growth DCTH
Operating Margin (TTM) Profitability 32.3% 5.2% Higher Margin IRMD
Net Profit Margin Profitability 26.9% 6.0% Higher Margin IRMD
Return on Equity (ROE) Capital Efficiency 23.4% 5.4% Higher ROE IRMD
52-Week Range Position Momentum 26% ($76โ€“$108) 80% ($8โ€“$23) Stronger Trend DCTH
Beta / 30D Volatility Risk Regime 0.73ฮฒ ยท 55% Vol 1.63ฮฒ ยท 131% Vol Lower Realized Risk IRMD
Unified Institutional Score Composite Signal 40.3 / 100 (SELL) 35.9 / 100 (SELL) Higher Composite IRMD

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full IRMD vs DCTH Buy Guide
IRMD CONSOLIDATION
94d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 5th %ile
IV Regime Compressed (<25th %ile)
Live IRMD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
DCTH BREAKOUT
66d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 43rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live DCTH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither IRMD nor DCTH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.